These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4588868)

  • 21. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
    Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
    Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine leukemia virus-associated cell surface antigens in rats neonatally infected with Gross murine leukemia virus.
    Basch RS; Grausz D; Harris N; Mitchison NA
    J Natl Cancer Inst; 1979 Dec; 63(6):1485-92. PubMed ID: 292817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of azathioprine-feeding or bone marrow transplantation on leukemogenic activity of N-butyl-N-nitrosourea (BNU) in Donryu rats (I). Sequential observations of immunological and histological changes in the subacute state].
    Furuta K; Ogiu T; Matsuoka C; Maekawa A
    Eisei Shikenjo Hokoku; 1984; (102):62-6. PubMed ID: 6398095
    [No Abstract]   [Full Text] [Related]  

  • 24. Protection of C58 mice by normal murine tissues against transplantable leukemia, line Ib.
    Han IH; Johnson AG; Murphy WH
    J Natl Cancer Inst; 1969 May; 42(5):815-24. PubMed ID: 5785010
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytotoxicity in vitro of preleukaemic lymphoid cells on syngeneic monolayers of embryo or thymus cells.
    Wahren B; Metcalf D
    Clin Exp Immunol; 1970 Sep; 7(3):373-86. PubMed ID: 5477935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

  • 27. [The type specific antigen of Gross leukemia virus in tumors and normal tissues and its identification by immunodiffusion methods].
    Lezhneva OM
    Biull Eksp Biol Med; 1976 Feb; 81(2):217-9. PubMed ID: 819062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of leupeptin on induction of lymphoblastic leukemia in mice by N-nitrosobutylurea.
    Kakizoe T; Sano T; Kawachi T; Sugimura T; Takeuchi T
    Gan; 1977 Jun; 68(3):281-5. PubMed ID: 269841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The leukemogenic action of phorbol.
    Berenblum I; Lonai V
    Cancer Res; 1970 Nov; 30(11):2744-8. PubMed ID: 4922468
    [No Abstract]   [Full Text] [Related]  

  • 30. The structural proteins of murine leukemia virus and the pathogenesis of necrotizing arteritis and glomerulonephritis in SL/Ni mice.
    Yoshiki T; Hayasaka T; Fukatsu R; Shirai T; Itoh T; Ikeda H; Katagiri M
    J Immunol; 1979 May; 122(5):1812-20. PubMed ID: 221579
    [No Abstract]   [Full Text] [Related]  

  • 31. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus.
    Sharma JM; Herberman RB; Djeu JY; Nunn ME
    J Immunol; 1979 Jul; 123(1):222-31. PubMed ID: 221590
    [No Abstract]   [Full Text] [Related]  

  • 34. Alteration of skin in gross leukemia. V. Refutation of virus involvement.
    Mariani T; Maruyama Y
    J Natl Cancer Inst; 1974 Dec; 53(6):1661-4. PubMed ID: 4612164
    [No Abstract]   [Full Text] [Related]  

  • 35. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nature and complexity of the FMR antigenic system.
    Bismuth A; Kremsdorf D; Debré P; Levy JP
    Eur J Immunol; 1979 Aug; 9(8):632-9. PubMed ID: 556553
    [No Abstract]   [Full Text] [Related]  

  • 37. [Carcinogenic action of n-butylnitrosourea in adult Sprague-Dawley-rats by special consideration of its leukemogenic action after its chronic application in drinking water (author's transl)].
    Gonsior D; Zeller WJ; Ivankovic S; Schmähl D
    Arch Geschwulstforsch; 1974; 43(3):239-43. PubMed ID: 4603374
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-specific antigens and immunoglobulin synthesis of murine myeloma cells and their variants.
    Hyman R; Ralph P; Sarkar S
    J Natl Cancer Inst; 1972 Jan; 48(1):173-84. PubMed ID: 4119881
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of antilymphocyte serum on the induction of neoplasms of lymphoreticular tissues.
    Law LW
    Fed Proc; 1970; 29(1):171-4. PubMed ID: 4312738
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune complexes localized in the renal glomeruli of AKR mice: the presence of MuLV gs-I and C-type RNA tumor virus gs-3 determinants.
    Markham RV; Sutherland JC; Cimino EF; Drake WP; Mardiney MR
    Rev Eur Etud Clin Biol; 1972; 17(7):690-4. PubMed ID: 4119502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.